Drug Profile
Research programme: viral vaccines - Mymetics Corporation
Alternative Names: Chikungunya virus infections - Mymetics; Zika virus infection - MymeticsLatest Information Update: 24 Jun 2021
Price :
$50
*
At a glance
- Originator Mymetics Corporation
- Class Viral vaccines; Zika virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chikungunya virus infections; Zika virus infection
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for research development in Chikungunya-virus-infections in Netherlands
- 28 Jun 2020 No recent reports of development identified for research development in Zika-virus-infection in Netherlands
- 28 Jan 2016 Early research in Chikungunya virus infections in Netherlands (unspecified route)